Agarwal Sunil

EVP, Head of Development & CMO at SANA; President of R & D at Juno Therapeutics, Inc.; Chief Medical Officer at RARE

Sold, on record
$4.3M
Dollars the filings state
Form 4 sales
14
Latest Sep 16, 2021
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale RAREPlan not stated
    Feb 22 2016

    Sold 658 shares at $63.48 ($42k)

    Agarwal Sunil, Chief Medical Officer

    Sold 5.8% of holdings ($718k position)10,650 shares left1.2x usual sizeFiling

  2. 2 Form 4 sale RAREPlan not stated
    Mar 22 +29 days

    Sold 650 shares at $61.45 ($40k)

    Agarwal Sunil, Chief Medical Officer

    Sold 6.3% of holdings ($630k position)9,608 shares left1.1x usual sizeFiling

  3. 3 Form 4 sale RAREPlan not stated
    Apr 20 +29 days

    Sold 649 shares at $70.53 ($46k)

    Agarwal Sunil, Chief Medical Officer

    Sold 7% of holdings ($650k position)8,567 shares left1.1x usual sizeFiling

  4. 4 Form 4 sale RAREPlan not stated
    May 24 +34 days

    Sold 650 shares at $66.00 ($43k)

    Agarwal Sunil, Chief Medical Officer

    Sold 8.4% of holdings ($512k position)7,111 shares left1x usual sizeFiling

  5. 5 Form 4 sale RAREPlan not stated
    Jun 20 +27 days

    Sold 650 shares at $54.16 ($35k)

    Agarwal Sunil, Chief Medical Officer

    Sold 5.8% of holdings ($608k position)10,569 shares left1x usual sizeFiling

  6. 6 Form 4 sale RAREPlan not stated
    Jul 21 +31 days

    Sold 649 shares at $52.68 ($34k)

    Agarwal Sunil, Chief Medical Officer

    Sold 6.4% of holdings ($536k position)9,528 shares left1x usual sizeFiling

  7. 7 Form 4 sale Juno Therapeutics, Inc.Plan not stated
    Oct 2 +438 days

    Sold 7,285 shares at $44.76 ($326k)

    Agarwal Sunil, President of R & D

    Sold 7.9% of holdings ($4.1M position)84,549 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale SANAPlan not stated
    Sep 16 +1445 days

    Sold 60,000 shares at $26.07 ($1.6M)

    Agarwal Sunil, EVP, Head of Development & CMO

    Sold 3.7% of holdings ($42M position)1.6M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Agarwal Sunil
Source
Sep 16, 2021SANAEVP, Head of Development & CMOForm 4 sale60,000$1.6M3.7%Plan not statedSEC
Oct 2, 2017Juno Therapeutics, Inc.President of R & DForm 4 sale7,285$326k7.9%Plan not statedSEC
Jul 21, 2016RAREChief Medical OfficerForm 4 sale649$34k6.4%Plan not statedSEC
Jun 20, 2016RAREChief Medical OfficerForm 4 sale650$35k5.8%Plan not statedSEC
May 24, 2016RAREChief Medical OfficerForm 4 sale650$43k8.4%Plan not statedSEC
Apr 20, 2016RAREChief Medical OfficerForm 4 sale649$46k7.0%Plan not statedSEC
Mar 22, 2016RAREChief Medical OfficerForm 4 sale650$40k6.3%Plan not statedSEC
Feb 22, 2016RAREChief Medical OfficerForm 4 sale658$42k5.8%Plan not statedSEC
Jan 20, 2016RAREChief Medical OfficerForm 4 sale585$43k4.6%Plan not statedSEC
Dec 22, 2015RAREChief Medical OfficerForm 4 sale498$57k3.6%Plan not statedSEC
Nov 23, 2015RAREChief Medical OfficerForm 4 sale498$48k3.5%Plan not statedSEC
Oct 20, 2015RAREChief Medical OfficerForm 4 sale649$55k4.2%Plan not statedSEC
Sep 22, 2015RAREChief Medical OfficerForm 4 sale498$55k3.0%Plan not statedSEC
Aug 20, 2015RAREChief Medical OfficerForm 4 sale17,020$1.9M50.2%UnusualSEC